Key result
Homozygous CAST splicing variant co-segregates with DCM in ~100% of PLACK syndrome cases.
Why the study?
PLACK syndrome is an extremely rare autosomal recessive syndrome of defective epidermal adhesion caused by loss-of-function mutations in the CAST gene and mostly associated with dermatological manifestations.
Observational (n=38)
This study broadens the clinical spectrum of PLACK syndrome beyond cutaneous features by identifying fatal childhood-onset dilated cardiomyopathy associated with a homozygous CAST splicing variant (c.1209 + 2 T > G).
Answers are grounded in this paper and cite their sources.
May warrant cardiac monitoring in PLACK syndrome; extends phenotype but leaves open broader causality.
Background PLACK syndrome is an extremely rare autosomal recessive syndrome of defective epidermal adhesion and mostly associated with the typical dermatological manifestations. It is caused by loss of function mutations in CAST gene encoding calpastatin, a calcium dependent protease inhibitor of calpains. Methods Whole Exome Sequencing (WES) on genomic DNA from the index case followed by Sanger sequencing and segregation analysis of the identified variant in 38 individuals of 10 affected consanguineous families were performed. Results All affected individuals exhibited the typical dermatological manifestations of PLACK syndrome, followed by development of DCM, which generally occurs between the ages of 8 and 11 years. Without heart transplantation all patients will dead by developing DCM. WES, performed in the index case, identified a homozygous splicing variant (c.1209 + 2 T > G) in the CAST gene that could be the causative pathogenic mechanism responsible for DCM in association with PLACK syndrome. Sanger sequencing and segregation analysis revealed co-segregation of the variant with the disorder in all the patients. Conclusion The analysis of 15 individuals with PLACK syndrome substantially broadens the recognized clinical spectrum of the disorder and provides additional evidence for a potential association between the pathogenic variant and the observed phenotype. Our findings suggest that phenotypic manifestations of PLACK syndrome extend beyond and currently recognized cutaneous features and highlight the importance of comprehensive clinical assessment in affected individuals. Our findings confirm and suggest the splicing mutation (NM_001042440: (c.1209 + 2 T > G)) in CAST gene is a potential cause that associated with PLACK syndrome characterized by DCM.
No takes yet. Share an insight, caveat, or question.
Bahreini et al. (2026) conducted an observational in PLACK syndrome and dilated cardiomyopathy (DCM) (n=38). Homozygous CAST gene splicing variant (c.1209 + 2 T > G) was evaluated on Development of dilated cardiomyopathy (DCM) and co-segregation of the CAST variant. Homozygous CAST splicing variant (c.1209 + 2 T > G) co-segregated with PLACK syndrome and dilated cardiomyopathy in 100% of the 15 affected patients across 10 families.
Synapse has enriched 10 related papers. Consider them for comparative context: